RxDoctor Payments Data

Beau Kildow, MD

Orthopaedic Surgery · Omaha, NENPI 1780002436

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $297,015 of the $353,229 with a category attached, or 84.1%. Encore Medical, LP accounts for 68.0% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $137,045, more than ten times the $2,006 reported in 2019. Among orthopaedic surgery clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$353,229in general payments, 2019–2025

Across 406 payments — averaging $870.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$240K
  • Stryker$54K
  • Medacta USA, Inc.$35K
  • Smith+Nephew$10K
  • Medical Device Business Services, Inc.$4K
  • Heraeus Medical, LLC.$4K
  • plus $6K from 10 others

What the payments were for

  • Consulting fees$297,01584%
  • Speaking & faculty fees$1,0630%
  • Travel & lodging$43,93612%
  • Food & beverage$11,2163%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$353,229 in reported general payments places this provider in the 95th percentile of 155 orthopaedic surgery providers in Nebraska.

See all orthopaedic surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$366,696
Medicare patients
444
Services billed
1,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone39$287
Amoxicillin152$175
Tramadol Hcl13$116
Clindamycin Hcl52$93
Cephalexin12$62
Azithromycin15$37

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →